Susquehanna Maintains Neutral on RXO, Raises Price Target to $30
Benzinga Newsdesk 7 hours ago
Analyst RatingsNewsPrice Target
Susquehanna analyst Harrison Bauer maintains RXO (NYSE:RXO) with a Neutral and raises the price target from $19 to $30.
Susquehanna analyst Harrison Bauer maintains RXO (NYSE:RXO) with a Neutral and raises the price target from $19 to $30.